GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Japanese
Top Page
About Us
R&D
Investor Relations
Contact Us
[Japanese]
Latest Information
Read more
02/14/2019
Information
Comments on recent inquiries
01/30/2019
Information
GNI Group Busines Operation Update
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(Etuary)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
Investor Relations
IR News
Financial Reports
Conference Material/Convocation Letter
TSE Filings
Bulletin Board
Information
Message
Business Model
Stock Quote
